Patients should be counseled to: Consume smaller, more frequent meals (56 per day) rather than large portions Emphasize low-fat, low-fiber foods that empty more readily from the stomach Ensure adequate hydration, particularly with liquid calories if solid food tolerance is poor Avoid lying down immediately after meals Chew food thoroughly and eat slowly For patients developing concerning symptoms, temporary dose reduction or treatment interruption may be necessary
When in doubt, its better to err on the side of caution
This guide sets the two side by side on mechanism, weight-loss results, glycaemic and lipid effects, tolerability, dosing cadence and regulatory status, and flags every point where the evidence is early or indirect
This question is increasingly relevant as tirzepatide (Mounjaro, Zepbound) gains prominence in managing type 2 diabetes and obesity
Medicare usually doesnt cover semaglutide for weight loss but will provide coverage if used for type 2 diabetes